Home »

Clinical Trial Follow-up Confirms Discontinuation of Intensive Blood Glucose Control Results in Reversal of A1c Improvement

ATLANTA, GA — (Marketwire) — 07/28/11 — ALR Technologies Inc. (OTCBB: ALRT) announces follow-up results of a clinical trial with diabetes patients has been published in the Canadian Journal of Diabetes, July 2011 issue. The trial was headed by Dr. Hugh Tildesley, a leading endocrinologist in Canada, and the paper can be viewed at:Dr. Tildesley conducted a 12 month study using the ALRT Health-e-Connect (HeC) System as an Internet Based Blood Glucose Monitoring System (IBGMS) to provide inten

Analytics

© 2020 88Finance. All Rights Reserved. Log in - Copyright by LayerMedia


Blogverzeichnis - Blog Verzeichnis bloggerei.de Blog Top Liste - by TopBlogs.de